What is CBD
Updated: Jul 8, 2022
CBDa is only one of more than 100 cannabinoids in the cannabis plant. But it is one of the most important contributors to the homeostasis of all those who consume it. While most consumers are more familiar with the active cannabinoid of CDB or THC; their raw versions; CBDa and THCa contain important nutrients and are now considered a Super Food. Consuming raw or not yet decarbed cannabis is new to most people; even those who have been consumers for years.
There are 4 major areas that CBDa - or non psychoactive cannabis - can aid in.
In a 2008 study done on injured athletes CBDa was shown to have significant impact on inflammation. The use of CBDa both internally and externally can help with inflammation due to injury but also due to extended illnesses and arthritis.
A study done in 2012 shows great strides in fighting cancer with CBDa. The study's shows it helped extensively with Breast Cancers stopping the spreading of the cancer cells.
Nausea and vomiting can be stopped or controlled with consuming CBDa; showing a calming effect on the stomach. In fact, "It all began in 2008, when researchers noticed that the molecular structure of CBDA closely resembled that of other common nonsteroidal anti-inflammatory drugs (NSAIDs). The team then investigated the potential of CBDA to act as an anti-inflammatory agent and found that CBDA demonstrated the same COX-2 inhibitor behavior that enables NSAIDs to tackle inflammation.
CBDA is also thought to be a powerful treatment for nausea and anxiety. A 2013 study from scientists in Guelph, Canada, found that CBDA was a thousand times more powerful than CBD in binding to a specific serotonin receptor linked to anti-nausea and anti-anxiety effects when administered alongside low-doses of the traditional anti-nausea drug for chemotherapy patients, ondansetron (OND)." (https://www.analyticalcannabis.com/articles/cbda-vs-cbd-what-are-the-differences-312019)
For more information on CBDa and Dr Mechoulam, check out his speech from the 2019 CannMed conference on CBDa where he said, “In addition, we have provided several delivery mechanisms including tablets, topical applications and others to facilitate several approaches,” said Mechoulam. “Our work is a catalyst for the development of potential new therapies from a source long thought to have huge potential.”
He is, after all, the foremost authority on Cannabis in the world. His record breaking research led to the discovery of the Endocannabinoid system and the subsequent research has proven time and again the medical benefits of cannabis.
